Cargando…
Cardiovascular Disease Risk in Children With Chronic Kidney Disease: Impact of Apolipoprotein C-II and Apolipoprotein C-III
Cardiovascular disease (CVD) is an evolving process that begins in the early stages of chronic kidney disease (CKD) in children. Several surrogate markers, such as ambulatory blood pressure monitoring (ABPM), left ventricular (LV) mass, and arterial stiffness assessment, allow for the early detectio...
Autores principales: | Chen, Wei-Ling, Tain, You-Lin, Chen, Hung-En, Hsu, Chien-Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397580/ https://www.ncbi.nlm.nih.gov/pubmed/34458211 http://dx.doi.org/10.3389/fped.2021.706323 |
Ejemplares similares
-
Apolipoprotein C-III and cardiovascular diseases: when genetics meet molecular pathologies
por: Dib, Israa, et al.
Publicado: (2021) -
Diagnostic value of apolipoprotein C-I, transthyretin and apolipoprotein C-III in gastric cancer
por: Wang, Min, et al.
Publicado: (2019) -
The Association Between Changes in Plasma Short-Chain Fatty Acid Concentrations and Hypertension in Children With Chronic Kidney Disease
por: Lu, Pei-Chen, et al.
Publicado: (2021) -
Apolipoprotein E in VLDL and LDL With Apolipoprotein C‐III is Associated With a Lower Risk of Coronary Heart Disease
por: Mendivil, Carlos O., et al.
Publicado: (2013) -
Distinct patterns of apolipoprotein C-I, C-II, and C-III isoforms are associated with markers of Alzheimer’s disease
por: Hu, Yueming, et al.
Publicado: (2020)